# Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer

> **NCT00056654** · NA · COMPLETED · sponsor: **Abbott** · enrollment: 164 (actual)

## Conditions studied

- Prostatic Neoplasms

## Interventions

- **DRUG:** Leuprolide acetate

## Key facts

- **NCT ID:** NCT00056654
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2004-07
- **Final completion:** 2004-07
- **Target enrollment:** 164 (ACTUAL)
- **Last updated:** 2008-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00056654

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00056654, "Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00056654. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*